BridgeMD
New treatment option for Neuromuscular Diseases (NMD)
Official title Personalized Training for People With Rare Neuromuscular Disorders
ClinicalTrials.gov ID: NCT06708468
What this study is testing
- What it's testing
- The goal of this study is to investigate the effects of personalized exercise treatment on dynamic balance and physical function in comparison with regular follow-up in adults with rare-neuromuscular disorders: Charcot-Marie-Tooth (CMT), Facioscapulohumeral Muscular Dystrophy (FSHD), and Myotonic Dystrophy Type 1 (DM1). The key objectives are: 1.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- A confirmed diagnosis of either FSHD, DM1 or CMT
- 18-70 years of age at the time of signing the informed consent.
- Any gender
- Ability to stand, rise from a chair and walk at least 10 meters with or without any need of assistive devices
- Indication for rehabilitation as confirmed by the treating neurologist or physiotherapist
You likely can't join if
- Pregnancy or planning to become pregnant
- Any other neurological or non-neurological disorders affecting physical capacity, such as disabling arthritis, severe heart-failure/cardiomyopathy...
- Alcohol or drug abuse as per their medical chart
- History of non-compliance to medical advice/follow-up
See the full eligibility criteria
- A confirmed diagnosis of either FSHD, DM1 or CMT
- 18-70 years of age at the time of signing the informed consent.
- Any gender
- Ability to stand, rise from a chair and walk at least 10 meters with or without any need of assistive devices
- Indication for rehabilitation as confirmed by the treating neurologist or physiotherapist
- Ability to understand and follow instructions in Norwegian
- Capable of giving signed informed consent
- Pregnancy or planning to become pregnant
- Any other neurological or non-neurological disorders affecting physical capacity, such as disabling arthritis, severe heart-failure/cardiomyopathy, on-going cancer treatment
- Alcohol or drug abuse as per their medical chart
- History of non-compliance to medical advice/follow-up
The study team makes the final eligibility decision.
Where it's taking place
- Bergen, Norway
- Molde, Norway
- Namsos, Norway
- Oslo, Norway
- Tromsø, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bergen, Norway; Molde, Norway; Namsos, Norway; Oslo, Norway; Tromsø, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.